What is JYNT's current stock price?

JYNT (The Joint Corp.) is currently trading at $8.93 with a market cap of $127.3M.

What sector is The Joint Corp. in?

The Joint Corp. (JYNT) operates in the Healthcare sector, specifically in the Medical - Care Facilities industry.

Is JYNT a good stock to buy?

Analysts have a Hold consensus on JYNT with a price target of $20.00. Check our detailed analysis for valuation, financials, and insider activity.

InvestLog

Back to Market返回行情

JYNT The Joint Corp.

USHealthcare

$8.93-0.22%ClosedMarket Cap: $127.3M

As of 2026-07-08 16:00

Why JYNT matters now

The Joint Corp. (JYNT) is a US stock in Healthcare. The latest InvestLog snapshot shows $8.93 with -0.22% on the session and $127.3M in market capitalization; recent performance reads 1-month +7.11% and YTD +7.11%.

The latest financial table shown here is Q1 2026, with revenue of $14.8M, net income of $1.3M, and EPS of $0.09. Investors can compare that operating picture with valuation signals such as P/E 43.01 and FCF yield 2.0%.

The latest indexable market news headline is "American Clean Resources Group Receives Letter of Intent for Up to $40 Million in Joint Development Capital to Advance Millers Solar Energy Zone Acquisition" from GlobeNewsWire.

Additional event context on this page matters because analyst consensus is Hold with a median target of $20.00; recent insider activity includes Bowman Scott Justin filing F-InKind. These signals are research inputs, not a recommendation.

Valuation

P/E (TTM)

43.01

PEG

0.32

P/B

8.56

P/S

2.35

EV/EBITDA

38.65

DCF Value

$2.69

FCF Yield

2.0%

Div Yield

0.0%

Margins & Returns

Gross Margin

79.9%

Operating Margin

1.2%

Net Margin

5.7%

ROE

16.9%

ROA

5.6%

ROIC

2.3%

Financials

Period	Revenue	Net Income	EPS
Q1 2026	$14.8M	$1.3M	$0.09
Q4 2025	$15.2M	$991.1K	$0.07
FY 2025	$54.9M	$2.9M	$0.19
Q3 2025	$13.4M	$855.0K	$0.06

Analyst Ratings

Consensus

Hold

Target (Consensus)

$20.00

Target (Median)

$20.00

Target Range

$20.00 - $20.00

Strong Buy: 0Buy: 1Hold: 3Sell: 0Strong Sell: 0

B. Riley SecuritiesBuy

2025-08-08

Trading Activity

Insider Trades

Bowman Scott Justinofficer: Chief Financial Officer

Sell2026-06-12

Pant Milinddirector

Sell2026-06-03

Rubel Matthew Edirector

Sell2026-05-22

DaVella Ronald Vdirector

Sell2026-05-22

Grandpre Christopher Mdirector

Sell2026-05-22

Related Stocks

APYX

Apyx Medical Corporation

Cognition Therapeutics, Inc.

Latest News

American Clean Resources Group Receives Letter of Intent for Up to $40 Million in Joint Development Capital to Advance Millers Solar Energy Zone AcquisitionGlobeNewsWire · 2026-07-06

Realty Income Forms Joint Venture: Can Data Centers Lift Growth?Zacks Investment Research · 2026-07-01

Cloud Capital Establishes Core Joint Venture Strategy Seeded with over $6 Billion of Assets with Realty Income and a Global Institutional InvestorPRNewsWire · 2026-07-01

The Joint Chiropractic Expands to 44th State with Opening of Rhode Island ClinicPRNewsWire · 2026-07-01

Realty Income Forms Programmatic Joint Venture with Cloud Capital and a Global Institutional Investor to Invest in Hyperscale Data Centers; Initial Seed Assets Valued at Over $6 BillionPRNewsWire · 2026-06-30

Company Info

Sector

Healthcare

Industry

Medical - Care Facilities

Country

Exchange

—

Beta

1.10

The Joint Corp. specializes in the establishment, proprietorship, operation, and overall administration of chiropractic treatment centers. Its business operations are structured into two main divisions: corporate-owned clinics and franchised facilities. The firm employs several strategic models for its expansion and day-to-day functioning, which include direct company ownership, various management agreements, licensing its brand to franchisees, and collaborating with regional development partners. As of March 1, 2022, the company maintained approximately 700 active locations throughout the United States. Founded in 2010, The Joint Corp. maintains its primary corporate headquarters in Scottsdale, Arizona.